share_log

Is DR (SZSE:301177) Using Debt Sensibly?

Is DR (SZSE:301177) Using Debt Sensibly?

DR(深圳證券交易所代碼:301177)是否明智地使用債務?
Simply Wall St ·  03/12 18:01

Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility of prices, but whether you will suffer a permanent loss of capital.' So it might be obvious that you need to consider debt, when you think about how risky any given stock is, because too much debt can sink a company. Importantly, DR Corporation Limited (SZSE:301177) does carry debt. But should shareholders be worried about its use of debt?

傳奇基金經理李露(由查理·芒格支持)曾經說過:“最大的投資風險不是價格的波動,而是你是否會遭受永久的資本損失。”因此,很明顯,當你考慮任何給定股票的風險時,你需要考慮債務,因爲過多的債務會使公司陷入困境。重要的是,DR Corporation Limited(深圳證券交易所代碼:301177)確實有債務。但是,股東是否應該擔心其債務的使用?

Why Does Debt Bring Risk?

爲什麼債務會帶來風險?

Debt and other liabilities become risky for a business when it cannot easily fulfill those obligations, either with free cash flow or by raising capital at an attractive price. If things get really bad, the lenders can take control of the business. However, a more frequent (but still costly) occurrence is where a company must issue shares at bargain-basement prices, permanently diluting shareholders, just to shore up its balance sheet. By replacing dilution, though, debt can be an extremely good tool for businesses that need capital to invest in growth at high rates of return. When we think about a company's use of debt, we first look at cash and debt together.

當企業無法通過自由現金流或以誘人的價格籌集資金來輕鬆履行這些義務時,債務和其他負債就會成爲風險。如果情況變得非常糟糕,貸款人可以控制業務。但是,更頻繁(但仍然昂貴)的情況是,公司必須以低廉的價格發行股票,永久稀釋股東,以支撐其資產負債表。但是,通過取代稀釋,對於需要資本以高回報率投資增長的企業來說,債務可以成爲一個非常好的工具。當我們考慮公司使用債務時,我們首先將現金和債務放在一起考慮。

How Much Debt Does DR Carry?

DR 揹負了多少債務?

As you can see below, at the end of September 2023, DR had CN¥319.2m of debt, up from CN¥285.1m a year ago. Click the image for more detail. But it also has CN¥5.01b in cash to offset that, meaning it has CN¥4.69b net cash.

如下所示,截至2023年9月底,德國的債務爲3.192億元人民幣,高於去年同期的2.851億加元。點擊圖片查看更多細節。但它也有50.1億元的現金來抵消這一點,這意味着它的淨現金爲46.9億元人民幣。

debt-equity-history-analysis
SZSE:301177 Debt to Equity History March 12th 2024
SZSE: 301177 2024 年 3 月 12 日債務與股權比率歷史記錄

A Look At DR's Liabilities

看看 DR 的負債

The latest balance sheet data shows that DR had liabilities of CN¥1.03b due within a year, and liabilities of CN¥160.0m falling due after that. Offsetting these obligations, it had cash of CN¥5.01b as well as receivables valued at CN¥84.5m due within 12 months. So it actually has CN¥3.91b more liquid assets than total liabilities.

最新的資產負債表數據顯示,DR的負債爲10.3億元人民幣,之後到期的負債爲1.60億元人民幣。除了這些債務外,它還有價值50.1億元人民幣的現金以及價值8,450萬元人民幣的應收賬款將在12個月內到期。所以它實際上有391億元人民幣 更多 流動資產超過總負債。

This luscious liquidity implies that DR's balance sheet is sturdy like a giant sequoia tree. Having regard to this fact, we think its balance sheet is as strong as an ox. Simply put, the fact that DR has more cash than debt is arguably a good indication that it can manage its debt safely. There's no doubt that we learn most about debt from the balance sheet. But ultimately the future profitability of the business will decide if DR can strengthen its balance sheet over time. So if you're focused on the future you can check out this free report showing analyst profit forecasts.

這種豐厚的流動性意味着DR的資產負債表像一棵巨型紅杉樹一樣堅固。考慮到這一事實,我們認爲其資產負債表像牛一樣強勁。簡而言之,DR的現金多於債務這一事實可以說是一個很好的跡象,表明它可以安全地管理債務。毫無疑問,我們從資產負債表中學到的關於債務的知識最多。但最終,該業務未來的盈利能力將決定DR能否隨着時間的推移加強其資產負債表。因此,如果您專注於未來,可以查看這份顯示分析師利潤預測的免費報告。

Over 12 months, DR made a loss at the EBIT level, and saw its revenue drop to CN¥2.4b, which is a fall of 44%. That makes us nervous, to say the least.

在過去的12個月中,DR在息稅前利潤水平上出現虧損,收入下降至24億元人民幣,下降了44%。至少可以說,這讓我們感到緊張。

So How Risky Is DR?

那麼 DR 的風險有多大?

While DR lost money on an earnings before interest and tax (EBIT) level, it actually booked a paper profit of CN¥31m. So taking that on face value, and considering the cash, we don't think its very risky in the near term. We'll feel more comfortable with the stock once EBIT is positive, given the lacklustre revenue growth. When analysing debt levels, the balance sheet is the obvious place to start. But ultimately, every company can contain risks that exist outside of the balance sheet. Be aware that DR is showing 3 warning signs in our investment analysis , and 1 of those is potentially serious...

儘管DR在利息稅前收益(EBIT)水平上蒙受了損失,但其實際賬面利潤爲3100萬元人民幣。因此,從面值來看,考慮到現金,我們認爲短期內風險不大。鑑於收入增長乏善可陳,一旦息稅前利潤爲正,我們將對該股感到更加滿意。在分析債務水平時,資產負債表是顯而易見的起點。但歸根結底,每家公司都可以控制資產負債表之外存在的風險。請注意,DR在我們的投資分析中顯示了3個警告信號,其中一個可能很嚴重...

If, after all that, you're more interested in a fast growing company with a rock-solid balance sheet, then check out our list of net cash growth stocks without delay.

畢竟,如果你對一家資產負債表堅如磐石的快速成長型公司更感興趣,那麼請立即查看我們的淨現金增長股票清單。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

對這篇文章有反饋嗎?對內容感到擔憂?直接聯繫我們。 或者,給編輯團隊 (at) simplywallst.com 發送電子郵件。
Simply Wall St的這篇文章本質上是籠統的。我們僅使用公正的方法根據歷史數據和分析師的預測提供評論,我們的文章無意作爲財務建議。它不構成買入或賣出任何股票的建議,也沒有考慮到您的目標或財務狀況。我們的目標是爲您提供由基本數據驅動的長期重點分析。請注意,我們的分析可能不考慮最新的價格敏感型公司公告或定性材料。簡而言之,華爾街沒有持有任何上述股票的頭寸。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論